In addition, a range of biochemical markers showed notable disparities between the patient cohort and healthy individuals.<h4>Conclusion</h4>According to the results of this current study, because the MALAT1 levels were significantly increased in AP cases, it could be postulated that MALAT1 can be used as a candidate biomarker in AP cases in order to diagnose the illness. Here, MALAT1 is linked to alkaline phosphatase measurement.